Blood Screening Market is valued at USD 2.66 Billion in 2021 and expected to reach USD 4.74 Billion by 2028 with a CAGR of 8.60% over the forecast period.
Blood Screening Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Blood Screening Market place for the forecast 2022– 2028.
Rising number of blood donors and blood donations, increasing prevalence of infectious diseases, increase in health care expenditure, increasing demand for donated blood, technological advancements in blood screening, and increasing awareness about health care are some of the major factors powering the development of the global blood screening market
Blood screening refers to various tests performed on blood samples for detection of different diseases such as syphilis, hepatitis, AIDS, and other clinical conditions such as pregnancy. It assists to prevent health issues and monitor diseases and a series of other conditions such as cancer and infections. Blood donor screening is the defense method used against the distribution of infection before blood donation.
The technology section of the global blood screening market comprises nucleic acid test, rapid tests, next generation sequencing, enzyme-linked immunosorbent assay, and western blot assay. The nucleic acid test section is sub-segmented into real-time polymerase chain reaction and transcription-mediated amplification. The enzyme-linked immunosorbent assay is divided into generation and platform. By product and services, the blood screening market is divided into reagents and kits, standards and controls, immunosorbents, buffers, sample diluents and wash solutions, conjugates, enzymes and polymerases, nucleotides and solutions, controls, software and services, substrates, probes and primers, labeling and detection reagents, and instruments. By end-user, the market includes hospitals and blood banks.
|Historical data||2018 - 2021|
|Forecast Period||2022 - 2028|
|Market Size in 2021:||USD 2.66 Billion|
|Base year considered||2021|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 4.74 Billion|
|Tables, Charts & Figures:||175|
|Blood Screening Companies||Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Danaher Corporation, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., Abbott Laboratories, Grifols, F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Siemens AG.|
|Segments Covered||By Technology Analysis, By Products & Services Analysis, By End-User Analysis|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
Rising Health Expenditure And Technological Advancements In The Blood Screening Process Are Powering The Blood Screening Market Development
Rising number of blood donors and blood donations, increasing prevalence of infectious diseases, rising awareness regarding maintaining of safety of donated blood, increase in health care expenditure, increasing demand for donated blood, technological advancements in blood screening, increasing adoption of nucleic acid testing, rising number of initiatives by various governments and government associations, and increasing awareness about health care are some of the major factors powering the development of the global blood screening market.
Increasing acceptance of nucleic acid testing, rising health expenditure, and technological advancements seen in the blood screening process are powering the blood screening market development all over the world. Initiatives undertaken by different governments for healthcare are making new growth avenues for the global blood screening market. The major factors that power the development of the global blood screening market include rise in number of blood donations, increase in prevalence of infectious diseases, surge in adoption of nucleic acid amplification test (NAT), and increase in awareness about healthcare. Furthermore, increase in healthcare expenditure, rise in healthcare initiatives by government, and technological advancements in blood screening technologies have powered the market development.
North America Leads The Global Market For Blood Screening Owing To Increasing Prevalence Of Infectious Diseases
North America leads the global market for blood screening owing to increasing prevalence of infectious diseases and technological enhancements in blood screening methods in the region. This market is predicted to show high development in the coming years in Asia, with India and China being the quickest developing markets in Asia Pacific. The major driving factors for the blood screening market in developing nations are the improving health care infrastructure, large pool of patients, growing demand for donated blood, increasing disposable income, and rising government funding in the region.
By Technology Analysis
By Products & Services Analysis
By End-User Analysis
The major players included in the global blood screening market forecast are,
By Regional Analysis
Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
Kemp House, 152 - 160 City Road, London EC1V 2NX
© Copyright 2022-23 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®